Thymosin Beta-4 — reference
The full 43-amino-acid parent protein that TB-500 is a fragment of; an actin-sequestering protein involved in cell migration and repair.
Regulatory status
Not FDA-Approved. Not FDA-approved. Has been studied in clinical trials for dry eye and cardiac repair without reaching approval. Banned by WADA.
Reported cautions
Pharmacokinetics
Published figures give an elimination half-life of ~2 hours (animal PK). No robust human plasma half-life study identified.
This figure is tagged Limited data in our evidence system. The available data does not support a confident single figure, so this entry is flagged accordingly. Read any curve built from it as illustrative only. You can see the shape this implies between doses in the Half-Life Visualizer, and compare it against every other compound in the Half-Life Data Table. Our sourcing page explains what each tier means.
Remember that an estimated curve is a model built from a population figure, not a measurement of your blood. Individual clearance varies, and for depot injections the figure describes release from the injection site rather than the compound clearing. Half-life explained →
What Peptide Plug does and does not publish
This page carries regulatory status, general context and published pharmacokinetics. It carries no dose, frequency or cycle information — that is a deliberate editorial line, because dosing is a clinical decision rather than reference data. We also do not sell, supply, source or link to vendors for any compound.
Frequently asked
Is Thymosin Beta-4 FDA-approved?
What is the half-life of Thymosin Beta-4?
How reliable is that half-life figure?
What cautions are associated with Thymosin Beta-4?
Does Peptide Plug publish dosing for Thymosin Beta-4?
Does Peptide Plug sell Thymosin Beta-4?
Related tools
Free, no account required.